Modeling was performed with software Modeller using the NMR structure of native MVIIA (PDB: 1TTK) as the template. Two restraints have been set, including disulfide connections and distance of alpha-C between two terminal residues (using scripts introduced by https://salilab.org/modeller/manual/ node 24 and 28, respectively). The linear precursor of MVIIA-GS 11 was synthesized on Rink amide resins and matured peptide 12was obtained after oxidative folding. i: microwave-assisted Fmoc SPPS using PyBOP/DIEA (10/10 eq.); ii: deprotection and cleavage from resin support by TFA/TIS/H2O/thioanisol (89/5/5/1, v/v) for 1 h followed by ether precipitation. Oxidative folding was performed in the folding mixture containing reduced peptide precursors (10 µM), GSSG:GSH (10:100 eq), (NH4)2SO4 (2.0 M), phosphate buffer (0.1 M, pH 7.5), and reacted at 4°C for 30-48 h.
. MALDI-TOF MS spectra of M1B-TEBA 2a, M1B-S-TEBA 3a, M1B-MES 6a, M1B thiolactones 7a and reduced cM1B 8a. Figure S2 . Synthetic scheme for preparing native ω-conotoxin MVIIA and linear analog MVIIA-GS. (A) The linear precursor of MVIIA 9 was synthesized on Rink amide resins and matured peptide 10 was obtained after oxidative folding. (B) The linear precursor of MVIIA-GS 11 was synthesized on Rink amide resins and matured peptide 12was obtained after oxidative folding. i: microwave-assisted Fmoc SPPS using PyBOP/DIEA (10/10 eq.); ii: deprotection and cleavage from resin support by TFA/TIS/H2O/thioanisol (89/5/5/1, v/v) for 1 h followed by ether precipitation. Oxidative folding was performed in the folding mixture containing reduced peptide precursors (10 µM), GSSG:GSH (10:100 eq), (NH4)2SO4 (2.0 M), phosphate buffer (0.1 M, pH 7.5), and reacted at 4°C for 30-48 h.
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